Page last updated: 2024-08-21

isoxazoles and Happy Puppet Syndrome

isoxazoles has been researched along with Happy Puppet Syndrome in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	3 (75.00)	2.80

Authors

Authors	Studies
Copping, NA; Fink, KD; McTighe, SM; Silverman, JL	1
Eisold, A	1
Bird, LM; Burdine, RD; During, MJ; Heimer, G; Holcroft, C; Kolevzon, A; Melmed, RD; Ochoa-Lubinoff, C; Rakhit, A; Tan, WH; Thibert, RL; Visootsak, J	1
Egawa, K; Fukuda, A; Inoue, K; Kishino, T; Kitagawa, K; Kitagawa, M; Saitoh, S; Takayama, C; Takayama, M	1

Reviews

1 review(s) available for isoxazoles and Happy Puppet Syndrome

Article	Year
Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2021, Volume: 18, Issue:3 Topics: Angelman Syndrome; Animals; Anticonvulsants; Biological Products; Genetic Therapy; Humans; Isoxazoles; Neurodevelopmental Disorders; Recombinant Fusion Proteins; RNA, Antisense; Ubiquitin-Protein Ligases	2021

Article

Year

Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2021, Volume: 18, Issue:3

Topics: Angelman Syndrome; Animals; Anticonvulsants; Biological Products; Genetic Therapy; Humans; Isoxazoles; Neurodevelopmental Disorders; Recombinant Fusion Proteins; RNA, Antisense; Ubiquitin-Protein Ligases

2021

Trials

1 trial(s) available for isoxazoles and Happy Puppet Syndrome

Article	Year
The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome. Neurology, 2021, 02-16, Volume: 96, Issue:7 Topics: Adolescent; Adult; Angelman Syndrome; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; GABA Agonists; Humans; Isoxazoles; Male; Middle Aged; Treatment Outcome; Young Adult	2021

Other Studies

2 other study(ies) available for isoxazoles and Happy Puppet Syndrome

Article	Year
Upcoming market catalysts in Q3 2020. Nature reviews. Drug discovery, 2020, Volume: 19, Issue:7 Topics: Angelman Syndrome; Azo Compounds; Drug Approval; Fatty Acids; Humans; Isoxazoles; Muscular Atrophy, Spinal; Pyrimidines; Triglycerides; United States	2020
Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome. Science translational medicine, 2012, Dec-05, Volume: 4, Issue:163 Topics: Angelman Syndrome; Animals; Cerebellum; Disease Models, Animal; GABA Agonists; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Isoxazoles; Mice; Purkinje Cells; Ubiquitin-Protein Ligases	2012

Article

Year

Upcoming market catalysts in Q3 2020.

Nature reviews. Drug discovery, 2020, Volume: 19, Issue:7

Topics: Angelman Syndrome; Azo Compounds; Drug Approval; Fatty Acids; Humans; Isoxazoles; Muscular Atrophy, Spinal; Pyrimidines; Triglycerides; United States

2020

Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome.

Science translational medicine, 2012, Dec-05, Volume: 4, Issue:163

Topics: Angelman Syndrome; Animals; Cerebellum; Disease Models, Animal; GABA Agonists; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Isoxazoles; Mice; Purkinje Cells; Ubiquitin-Protein Ligases

2012